Full Text View
Tabular View
No Study Results Posted
Related Studies
Cystagon to Treat Infantile Neuronal Ceroid Lipofuscinosis
This study is currently recruiting participants.
Study NCT00028262   Information provided by National Institutes of Health Clinical Center (CC)
First Received: December 17, 2001   Last Updated: August 24, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Neuronal Ceroid-Lipofuscinoses
More general conditions related to this trial
Genetic Diseases, Inborn
Heredodegenerative Disorders, Nervous System
Lipid Metabolism Disorders
Lipid Metabolism, Inborn Errors
Lipidoses
Metabolic Diseases
Metabolism, Inborn Errors
Nervous System Diseases
Neurodegenerative Diseases
Interventions listed in this trial
Cystagon
Additional drug interventions recognized in this trial
Cysteamine
More general drug interventions related to this trial
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Radiation-Protective Agents
Sponsors listed in this trial
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services